Transformation of CD5-Negative Follicular Lymphoma into CD5-Positive Diffuse Large B-Cell Lymphoma: A Case Report |
Kim, Hyeong-Kug
(Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine)
Cho, In-Sung (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) Lee, Hye-Kyung (Department of Pathology, Eulji University Hospital, Eulji University School of Medicine) Choi, Yong-Hun (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) Cho, Seong-Min (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) Moon, Hyun-Jin (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) Lee, Jin-A (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) |
1 | Kim JM, Ko YH, Lee SS, et al. WHO classification of malignant lymphomas in Korea: report of the third nationwide study. Korean J Pathol 2011;45:254-260. DOI |
2 | Lee Y, Kyung SY, Choi SJ, et al. Two cases of interstitial pneumonitis caused by rituximab therapy. Korean J Intern Med 2006;21:183-186. DOI ScienceOn |
3 | Lossos IS, Gascoyne RD. Transformation of follicular lymphoma. Best Pract Res Clin Haematol 2011;24:147-163. DOI ScienceOn |
4 | Maeshima AM, Taniguchi H, Nomoto J, et al. Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome). Am J Clin Pathol 2009;131:339-346. DOI ScienceOn |
5 | Yamaguchi M, Ohno T, Oka K, et al. De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome. Br J Haematol 1999;105:1133-1139. DOI ScienceOn |
6 | Sekiguchi Y, Imai H, Wakabayashi M, et al. CD5-positive follicular lymphoma: a case report and literature review. Intern Med 2011;50:899-904. DOI ScienceOn |
7 | Burastero SE, Casali P. Characterization of human CD5 (Leu-1, OKT1)+ B lymphocytes and the antibodies they produce. Contrib Microbiol Immunol 1989;11:231-262. |
8 | Pospisil R, Silverman GJ, Marti GE, Aruffo A, Bowen MA, Mage RG. CD5 is apotential selecting ligand for B-cell surface immunoglobulin: a possible role in maintenance and selective expansion of normal and malignant B cells. Leuk lymphoma 2000;36:353-365. DOI ScienceOn |
9 | Williams CD, Harrison CN, Lister TA, et al. High-dose therapy and autologus stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a-case matched study from the European Bone Marrow Transformed follicular lymphoma. Eur J Haemaetol 2000; 65:17-22. DOI ScienceOn |
10 | Bernstein SH, Burack WR. The incidence, natural history, biology, and treatment of transformed lymphomas. Hematology Am Soc Hematol Educ Program 2009:532-541. |